Development of tablets containing semipurified extract of guaraná (Paullinia cupana)

Detalhes bibliográficos
Autor(a) principal: Klein,Traudi
Data de Publicação: 2013
Outros Autores: Longhini,Renata, Bruschi,Marcos Luciano, Mello,João Carlos Palazzo de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Farmacognosia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2013000100026
Resumo: This study evaluated the technological feasibility of producing a semipurified extract of guaraná (Paullinia cupana Kunth, Sapindaceae) in tablet form, using a direct-compression process. Maltodextrin and gum arabic were used to produce the extract microparticles, in order to protect the microparticles against such factors as temperature, oxidation, and humidity. Using pharmacopoeial methodologies, technological and physicochemistry tests (determination of residual moisture, of bulk and tapped density, Hausner ratio, compressibility and compactibility index, appearance, mean weight, hardness, friability, disintegration time, determination of EPA amount in tablets and in vitro release profile) were conducted. The formulation containing 200 mg of microparticles, 170 mg microcrystalline cellulose, and 10 mg lactose gave the best results in terms of hardness (116 N), friabilility (0.28%), mean weight (0.3821 g), and disintegration time (25 min) for a tablet designed for oral administration. The results met pharmacopoeial specifications, and the tablets are suitable for oral administration.
id SBFGNOSIA-1_84715f1b36b09b2d141b8db8244cc292
oai_identifier_str oai:scielo:S0102-695X2013000100026
network_acronym_str SBFGNOSIA-1
network_name_str Revista Brasileira de Farmacognosia (Online)
repository_id_str
spelling Development of tablets containing semipurified extract of guaraná (Paullinia cupana)guaranálactosemicrocrystalline cellulosemicroparticlesPaullinia cupanatabletsThis study evaluated the technological feasibility of producing a semipurified extract of guaraná (Paullinia cupana Kunth, Sapindaceae) in tablet form, using a direct-compression process. Maltodextrin and gum arabic were used to produce the extract microparticles, in order to protect the microparticles against such factors as temperature, oxidation, and humidity. Using pharmacopoeial methodologies, technological and physicochemistry tests (determination of residual moisture, of bulk and tapped density, Hausner ratio, compressibility and compactibility index, appearance, mean weight, hardness, friability, disintegration time, determination of EPA amount in tablets and in vitro release profile) were conducted. The formulation containing 200 mg of microparticles, 170 mg microcrystalline cellulose, and 10 mg lactose gave the best results in terms of hardness (116 N), friabilility (0.28%), mean weight (0.3821 g), and disintegration time (25 min) for a tablet designed for oral administration. The results met pharmacopoeial specifications, and the tablets are suitable for oral administration.Sociedade Brasileira de Farmacognosia2013-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2013000100026Revista Brasileira de Farmacognosia v.23 n.1 2013reponame:Revista Brasileira de Farmacognosia (Online)instname:Sociedade Brasileira de Farmacognosia (SBFgnosia)instacron:SBFGNOSIA10.1590/S0102-695X2012005000147info:eu-repo/semantics/openAccessKlein,TraudiLonghini,RenataBruschi,Marcos LucianoMello,João Carlos Palazzo deeng2013-03-28T00:00:00Zoai:scielo:S0102-695X2013000100026Revistahttp://www.sbfgnosia.org.br/revista/https://old.scielo.br/oai/scielo-oai.phprbgnosia@ltf.ufpb.br1981-528X0102-695Xopendoar:2013-03-28T00:00Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia)false
dc.title.none.fl_str_mv Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
title Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
spellingShingle Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
Klein,Traudi
guaraná
lactose
microcrystalline cellulose
microparticles
Paullinia cupana
tablets
title_short Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
title_full Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
title_fullStr Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
title_full_unstemmed Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
title_sort Development of tablets containing semipurified extract of guaraná (Paullinia cupana)
author Klein,Traudi
author_facet Klein,Traudi
Longhini,Renata
Bruschi,Marcos Luciano
Mello,João Carlos Palazzo de
author_role author
author2 Longhini,Renata
Bruschi,Marcos Luciano
Mello,João Carlos Palazzo de
author2_role author
author
author
dc.contributor.author.fl_str_mv Klein,Traudi
Longhini,Renata
Bruschi,Marcos Luciano
Mello,João Carlos Palazzo de
dc.subject.por.fl_str_mv guaraná
lactose
microcrystalline cellulose
microparticles
Paullinia cupana
tablets
topic guaraná
lactose
microcrystalline cellulose
microparticles
Paullinia cupana
tablets
description This study evaluated the technological feasibility of producing a semipurified extract of guaraná (Paullinia cupana Kunth, Sapindaceae) in tablet form, using a direct-compression process. Maltodextrin and gum arabic were used to produce the extract microparticles, in order to protect the microparticles against such factors as temperature, oxidation, and humidity. Using pharmacopoeial methodologies, technological and physicochemistry tests (determination of residual moisture, of bulk and tapped density, Hausner ratio, compressibility and compactibility index, appearance, mean weight, hardness, friability, disintegration time, determination of EPA amount in tablets and in vitro release profile) were conducted. The formulation containing 200 mg of microparticles, 170 mg microcrystalline cellulose, and 10 mg lactose gave the best results in terms of hardness (116 N), friabilility (0.28%), mean weight (0.3821 g), and disintegration time (25 min) for a tablet designed for oral administration. The results met pharmacopoeial specifications, and the tablets are suitable for oral administration.
publishDate 2013
dc.date.none.fl_str_mv 2013-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2013000100026
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-695X2013000100026
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0102-695X2012005000147
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Farmacognosia
publisher.none.fl_str_mv Sociedade Brasileira de Farmacognosia
dc.source.none.fl_str_mv Revista Brasileira de Farmacognosia v.23 n.1 2013
reponame:Revista Brasileira de Farmacognosia (Online)
instname:Sociedade Brasileira de Farmacognosia (SBFgnosia)
instacron:SBFGNOSIA
instname_str Sociedade Brasileira de Farmacognosia (SBFgnosia)
instacron_str SBFGNOSIA
institution SBFGNOSIA
reponame_str Revista Brasileira de Farmacognosia (Online)
collection Revista Brasileira de Farmacognosia (Online)
repository.name.fl_str_mv Revista Brasileira de Farmacognosia (Online) - Sociedade Brasileira de Farmacognosia (SBFgnosia)
repository.mail.fl_str_mv rbgnosia@ltf.ufpb.br
_version_ 1752122468265361408